Britain first to approve AstraZeneca-Oxford COVID-19 vaccine
Reuters / Updated: Dec 30, 2020, 13:14 IST
coronavirus vaccine developed by
Oxford University and
AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus. AstraZeneca said the authorisation was for a two-dose regime, and that the vaccine had been approved for use for emergency supply. Britain has ordered 100 million doses of the vaccine. The government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca s
COVID-19 vaccine for use, the health ministry said. The pandemic has already killed 1.7 million people around the world, sown chaos through the global economy and upended normal life for billions since it began in Wuhan, China, a year ago.
Britain approves use of AstraZeneca-Oxford COVID-19Â vaccine
Britain on Wednesday became the first country to authorize an easy-to-handle COVID-19 vaccine whose developers hope it will become the vaccine for the world. The approval and a shift in policy that will speed up rollout of the vaccine in the United Kingdom comes as a surge in infections threatens to swamp British hospitals.
Social Sharing
The Associated Press ·
U.K. approves AstraZeneca vaccine amid soaring COVID-19 cases
The National3 months ago
4:08
The U.K. has approved the Oxford-AstraZeneca coronavirus vaccine for use four weeks after officials approved the Pfizer-BioNTech vaccine. The approval comes as the country faces record hospitalizations and stricter lockdown measures.4:08
U.K. approves emergency use of Oxford-AstraZeneca COVID-19 vaccine By Tucker Reals U.K. approves Oxford-AstraZeneca vaccine
The COVID-19 vaccine developed in Britain by Oxford University and AstraZeneca has been approved by the U.K. government for emergency use, the pharmaceutical company announced early Wednesday morning. Approval of the vaccine, which is cheaper to produce and easier to transport and store than the other vaccines already approved in the U.K. and the U.S., will be a welcome weapon in the fight against the coronavirus as infections surge on both sides of the Atlantic.
The British Department of Health and Social Care confirmed in a statement that it had accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorize Oxford University/AstraZeneca s Covid-19 vaccine for use. This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the v